Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
RevMab
anti-HER2 (human), Rabbit Monoclonal (RM228)
459
CHF
CHF 459.00
In stock
REV-31-1107-00-R100100 µlCHF 459.00
Figure 1: Immunohistochemical staining of FFPE humanbreast cancer tissue sections
| Product Details | |
|---|---|
| Synonyms | Receptor Tyrosine-protein Kinase erbB-2; Metastatic Lymph Node Gene 19 Protein; MLN19; Neu; c-ErbB-2; p185erbB2; CD340 |
| Product Type | Recombinant Antibody |
| Properties | |
| Clone | RM228 |
| Isotype | Rabbit IgG |
| Source/Host | Rabbit |
| Immunogen/Antigen | A peptide corresponding to the C-terminus of Human c-erbB-2/HER-2. |
| Application |
Immunohistochemistry (IHC): 1:100 dilution |
| Crossreactivity | Human |
| Specificity |
This antibody reacts to Human c-erbB-2/HER-2. This antibody may also react to mouse or rat c-erbB-2/HER-2, as predicted by immunogen homology. |
| Purity | Protein A purified. |
| Purity Detail | Protein A affinity purified from an animal origin-free culture supernatant. |
| Concentration | N/A |
| Formulation | Liquid. 50% Glycerol/PBS with 1% BSA and 0.09% sodium azide. |
| Isotype Negative Control | |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Accession Number | P04626 |
| Declaration | Manufactured by RevMab Biosciences. |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Long Term Storage | -20°C |
| Handling Advice | Avoid freeze/thaw cycles. |
| Use/Stability | Stable for at least 1 year after receipt when stored at -20°C. |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family. Amplification or over-expression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer and has become an important biomarker and target of therapy of breast cancer patients.